Akt2 expression is associated with good long-term prognosis in oestrogen receptor positive breast cancer

MLA

Bo Nordenskjöld, et al. “Akt2 Expression Is Associated with Good Long-Term Prognosis in Oestrogen Receptor Positive Breast Cancer.” European Journal of Cancer (Oxford, England : 1990), vol. 49, no. 6, June 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7a8e224bfb8cac7a0b39be4f64e79c92&authtype=sso&custid=ns315887.

APA

Bo Nordenskjöld, John Carstensen, Gizeh Pérez-Tenorio, Tommy Fornander, Helena Fohlin, Olle Stål, & Lambert Skoog. (2012). Akt2 expression is associated with good long-term prognosis in oestrogen receptor positive breast cancer. European Journal of Cancer (Oxford, England : 1990), 49(6).

Chicago

Bo Nordenskjöld, John Carstensen, Gizeh Pérez-Tenorio, Tommy Fornander, Helena Fohlin, Olle Stål, and Lambert Skoog. 2012. “Akt2 Expression Is Associated with Good Long-Term Prognosis in Oestrogen Receptor Positive Breast Cancer.” European Journal of Cancer (Oxford, England : 1990) 49 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7a8e224bfb8cac7a0b39be4f64e79c92&authtype=sso&custid=ns315887.